BRK-B vs HGLB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
The deterministic health profile is critical, with a Piotroski F-Score of 1/9 indicating severe financial weakness. While the stock appears deeply undervalued with a P/E of 2.87 and an intrinsic value of $19.95, the technical trend is completely bearish (0/100) and insider sentiment is weak. The high dividend yield of 12.71% is the primary attraction, but the fundamental health deterioration suggests a potential value trap.
Compare Another Pair
Related Comparisons
BRK-B vs HGLB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Highland Global Allocation Fund (HGLB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.